Filter Results:
(324)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow View Details
Keywords: by Regina E. Herzlinger
- 05 May 2020
- News
“Walking a Tightrope”
is going to be transmitted yet again to the next generation. A year and a half, two years ago now, we ran into Drew. He was in a drug treatment program called Provoking Hope based in McMinnville, Oregon.... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details
- 01 Sep 2006
- News
Redefining Health Care
high costs understandable. What Wennberg and others did was to show that U.S. health care also has severe quality problems. Indeed, there is every possible quality problem you can imagine: incorrect diagnoses, drug errors, unnecessary... View Details
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs and increased revenues from $15... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
the cost of paying for health insurance subscribers, which will bring higher returns for the insurance company. We have seen this in the drug Angiomax by the Medicines Company. —Suleiman Yakasai (PLDA 22, 2016) Got a case? To take part in... View Details
Keywords: Jen McFarland Flint
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
in on a treatment for age-related macular degeneration, a leading cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia’s View Details
- 01 Jun 2015
- News
Rebooting Europe
targeted effort to improve Ebola treatments resulted in development of an antiviral drug with potential to treat the early stages of the disease. Better research, Moedas says, also requires better support... View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
conclusion by manually going through the data,” the lead doctor told the Japan Times, “but Watson’s speed is crucial in the treatment of leukemia, which progresses rapidly and can cause complications.” This is the beauty of Watson, which... View Details
Keywords: Paul Kix; illustrations by Dan Page
- 28 Jul 2015
- First Look
First Look: July 28, 2015
of Dublin, Ireland-based Elan Drug Technologies (EDT)-a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case... View Details
Keywords: Carmen Nobel
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 04 Nov 2016
- News
The Competitiveness of Lost Causes
regulations, in part by helping producers secure public guarantees for financing a $17 million water treatment plant. “That was a success story that saved and created jobs and became the basis of an HBS case,” notes Duch. “Today everyone... View Details
Keywords: Deborah Blagg
- 01 Mar 2009
- News
Model Patient
care, plus some drug coverage — was rejected. It smacked of a “two-tiered” system, he says, and was unacceptable for political reasons. Costs have thus been significantly higher than expected because the standard plan — with a relatively... View Details
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed... View Details
Keywords: by Carmen Nobel & Anna Secino
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
potential for multiple breakthroughs related to the specific tumor segmentation task of radiation oncologists while also addressing technological issues (e.g., reframing and conducting sequential competition phases). Lagace: What made this problem in cancer View Details
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by... View Details
- 01 Mar 2013
- News
Opening the Door
neighborhood-based health plan for the city of Charlestown, and I became involved in building a system of benchmarks for the various services that were being offered—everything from dental care to drug and alcohol abuse counseling. I... View Details